Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare the hypothyroid state in patients with thyroid cancer prepared either by placebo or L-T3 following L-T4 withdrawal in preparation for whole body scintigraphy. To evaluate the time needed for TSH elevation (> 30 mUI/L) on placebo vs. L-T3.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Patrice Perron
• Collaborator: Theramed co.

Criteria

Inclusion Criteria:

• Patients with well-differentiated thyroid cancer, with total thyroidectomy

• 18 y.o. or older

Exclusion Criteria:

• Use of rhTSH for Whole Body Scintigraphy preparation

• Non stable cardiac arrythmias

• Any condition impairing TSH elevation(glucocorticoid use, hypopituitarism)

• Allergy to Liothyronine

• Inability to give a consent